Cathie Wood Offloads Meta Stock While Mark Zuckerberg Celebrates Llama AI Success

On Wednesday, Cathie Wood-led Ark Invest made notable trades, including the sale of shares in Meta Platforms Inc. META. This move comes as Meta’s AI model, Llama, reached a significant milestone of 1 billion downloads, while the company faces ongoing privacy scrutiny.

The Meta Trade: Ark Invest’s ARK Innovation ETF ARKK sold 7,361 shares of the Mark Zuckerberg-led company. The sale was valued at approximately $4.3 million, based on Meta’s closing price of $584.06. This decision follows a previous sale of over $7 million worth of Meta shares on Monday as the company deals with privacy challenges and global expansion efforts. Notably, Ark also offloaded $1.26 million worth of Meta shares on Wednesday.

Despite these issues, Meta has relatively fared well in 2025, benefiting from lower leverage compared to other tech giants. Recently, Meta’s AI model, Llama, achieved a milestone of 1 billion downloads, as announced by Zuckerberg.

Other Key Trades:

Pre-IPO Offer: Get A Piece Of A Nearly $5T Global Opportunity By Joining BOXABL As An Early Shareholder At Just $0.80/Share

Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.

Share Price: $0.80

Min. Investment: $1,000

Valuation: $3.5B

Sold 850,762 shares of UiPath Inc. from ARKK and 14,822 shares from ARKF.
Sold 65,855 shares of Illumina Inc. from ARKK and 20,529 shares from ARKG.
Bought 140,089 shares of Iridium Communications Inc for ARKK, 14,875 shares for ARKQ, and 9,517 shares for ARKX.
Bought 20,201 shares of CRISPR Therapeutics AG for ARKK and 13,726 shares for ARKG.
Bought 68,441 shares of Intellia Therapeutics Inc. for ARKK and 27,938 shares for ARKG.

Image via Shutterstock

Read Next: